AG
NXTC icon

Algert Global’s NextCure NXTC Stock Holding History

Algert Global’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,906
Closed -$63K – 1234
2022
Q3 		$63K Hold
1,906
– – ﹤0.01% 1132
2022
Q2 		$107K Buy
1,906
+574
+43% +$30K 0.01% 1108
2022
Q1 		$78K Sell
1,332
-828
-38% -$51.8K 0.01% 1120
2021
Q4 		$156K Buy
2,160
+336
+18% +$28.1K 0.02% 886
2021
Q3 		$147K Buy
+1,824
New +$160K 0.02% 946

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Algert Global's NXTC Position: Q4 2022 in Review

Algert Global sold out of NextCure (NXTC) in Q4 2022, closing a stake of 1,906 shares — an estimated $63K sold.

Algert Global first reported a position in NXTC in Q3 2021 and held it in 5 quarters. The position peaked at $156K in Q4 2021. 45 funds tracked by Wall St. Rank hold NXTC as of Q4 2022.

  • Algert Global reported no remaining NextCure position as of Q4 2022 after selling out during the quarter.
  • Algert Global sold 1,906 NextCure shares in Q4 2022, an estimated $63K.
  • Algert Global first reported a position in NextCure in Q3 2021 and held it in 5 quarters.
  • Algert Global's NextCure position peaked at $156K in Q4 2021.
  • 45 funds tracked by Wall St. Rank held NextCure as of Q4 2022.

Based on Algert Global's 13F filing for Q4 2022, filed 14 Feb 2023.